Hepatitis Monthly
Official Journal of Research Center for Gastroenterology and Liver Diseases
Scopus by Title (Ref)
1. Measuring, Analyzing, and Presenting Work Productivity Loss in Randomized Controlled Trials: A Scoping Review
- Zhang W. , et al.
2. Acetyl-L-carnitine Slows the Progression from Prefrailty to Frailty in Older Subjects: A Randomized Interventional Clinical Trial
- Malaguarnera G. , et al.
3. Acylcarnitines: Nomenclature, Biomarkers, Therapeutic Potential, Drug Targets, and Clinical Trials
- Dambrova M. , et al.
4. Can L-carnitine reduce post-COVID-19 fatigue?
- Vaziri-harami R. , et al.
5. Hepatitis C Virus Infection Increases Fatigue in Health Care Workers
- Catania V.E. , et al.
6. Carnitine serum levels in frail older subjects
- Malaguarnera G. , et al.
7. Does l-carnitine supplementation affect serum levels of enzymes mainly produced by liver? A systematic review and meta-analysis of randomized controlled clinical trials
- Pirmadah F. , et al.
8. Safety, efficacy and cost of two direct-acting antiviral regimens: A comparative study in chronic hepatitis C Egyptian patients
- Ibrahim Mohammed Ebid A.H. , et al.
9. Effects of L-carnitine supplementation on weight loss and body composition: A systematic review and meta-analysis of 37 randomized controlled clinical trials with dose-response analysis
- Talenezhad N. , et al.
10. Efficacy of L-carnitine on ribavirin-induced hemolytic anemia in patients with hepatitis C virus infection
- Sato S. , et al.
11. Acetyl-L-carnitine for patients with hepatic encephalopathy
- Martí-Carvajal A.J. , et al.
12. Resveratrol in hepatitis C patients treated with pegylated-interferon-α-2b and ribavirin reduces sleep disturbance
- Pennisi M. , et al.
15. The mixture of bifidobacterium associated with fructooligosaccharides reduces the damage of the ocular surface
- Chisari G. , et al.
16. Functional stress and microbiota eye in subjects with type 2 diabetes: A multifactorial approach
- Chisari E. , et al.
17. Amniotic membrane use in type 2 diabetes patients with chronic ulcers: Microbiological evaluation and therapeutic benefits
- Giuseppe C. , et al.
18. Silybin supplementation during HCV therapy with pegylated interferon-a plus ribavirin reduces depression and anxiety and increases work ability
- Malaguarnera G. , et al.
19. Hepatocellular carcinoma and the risk of occupational exposure
- Rapisarda V. , et al.
20. Effects of preventive versus "on-demand" nutritional support on paid labour productivity, physical exercise and performance status during PEG-interferon-containing treatment for hepatitis C
- Huisman E.J. , et al.
21. Chronic hepatitis C: This and the new era of treatment
- Bertino G. , et al.
22. Type II mixed cryoglobulinemia in patients with Hepatitis C Virus: Treatment with pegylated-interferon and Ribavirin
- Malaguarnera M. , et al.
23. The immune system in hepatocellular carcinoma and potential new immunotherapeutic strategies
- Bertino G. , et al.